Certification Rate
100%
Very high DOL cert
A DOL Labor Condition Application record spanning FY2023–2026. Review the filing volume, DOL certification record, and offered-wage context below.
New Brunswick, NJ NAICS: 5417
U.S. Department of Labor's OFLC discloses 21 Labor Condition Application filings naming Janssen pharmaceuticals Inc from FY2023 through FY2026, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 24 H-1B petitions naming Janssen pharmaceuticals Inc through FY2024, and approved the large majority of them: 95.8% approved (23 approvals, 1 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Janssen pharmaceuticals Inc is listed in 21 DOL LCA filings, more filings than 91% of employer filers in this extract. DOL certified 100% of those LCAs; the median listed offered wage is $172,489. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2026). Based in New Brunswick, NJ.
Janssen pharmaceuticals Inc vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
21 10911th of 122824 higher than 111,913 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2026
Derived from this employer's disclosed LCAs on file (FY2023–FY2026), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $119,925–$220,000 .
DOL LCA release change
On 21 LCAs with comparable offered vs prevailing wages, Janssen pharmaceuticals Inc averages about 29.3% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (61.9% of LCA filings).
Completed-year LCA counts rose from 1 in FY2023 to 6 in FY2025 (≈6×). Cumulative volume: 21.
Certification Rate
100%
Very high DOL cert
Avg. Salary
$172,489
Well above portal avg
Total Workers
21
Small worker count
Compensation range for H-1B positions at Janssen pharmaceuticals Inc
Wage vs. DOL Minimum
+29.3%
High vs DOL floor
national avg +17.8%
Typical DOL Wage Level
Fully Competent (Level IV)
61.9% of LCA filings
Full-Time Positions
100%
Primary Worksite County
MERCER, NJ
52.4% of LCA filings
Most frequently listed job titles at Janssen pharmaceuticals Inc
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| Senior Manager Global MPS | 2 | $161,000 |
| Associate Director, Head & Neck Data Strategy & Innovation | 2 | $220,000 |
| VP Global Commercial Quality | 1 | $219,166 |
| Staff Engineer, Automation - CAR-T | 1 | $123,000 |
| Mgr., Integrated Analytics, Commercial Insights & Strategy | 1 | $134,300 |
| Manager, PECS CIS Integrated Analytics – Immunology | 1 | $175,000 |
| Manager, Market Access and GTN Insights | 1 | $165,776 |
| Manager, Machine Learning and Data Engineering | 1 | $168,500 |
| Manager, Machine Learning & Data Engineering | 1 | $170,000 |
| Manager, Advanced Analytics | 1 | $160,400 |
| Manager, AI for Commercial Engagement (AA) | 1 | $167,600 |
| Manager, AI Products | 1 | $170,000 |
| Manager, AI & Machine Learning | 1 | $185,000 |
| Data Scientist Lead | 1 | $142,300 |
| CART QA Lead Exceptional Release | 1 | $119,925 |
Cross-state DOL neighbors for Janssen pharmaceuticals Inc - LCA filing-count and offered-wage axes, outside NJ.
Nearest cross-state employer filers by LCA filing count (21 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($172,489 here).
Janssen pharmaceuticals Inc is listed in 21 DOL Labor Condition Application filings covering 21 listed worker positions from FY2023 to FY2026. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, Janssen pharmaceuticals Inc ranks #10523 by total LCA filing count (21 filings). 111,913 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
Janssen pharmaceuticals Inc has a 100% DOL certification rate, with 21 out of 21 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in Janssen pharmaceuticals Inc's LCAs is $172,489. Listed wages range from $119,925 to $220,000 and are not verified actual compensation.
The top job titles in Janssen pharmaceuticals Inc's LCA filing records include Senior Manager Global MPS, Associate Director, Head & Neck Data Strategy & Innovation, VP Global Commercial Quality. The most common listed title is Senior Manager Global MPS with 2 LCA filings at an average listed offered wage of $161,000. This does not establish actual job openings, hiring, or approved petitions.
Janssen pharmaceuticals Inc is headquartered in New Brunswick, NJ. Their H-1B workers are distributed across 2 states, with the most positions in NJ, PA.
No, Janssen pharmaceuticals Inc is not classified as H-1B dependent.
Janssen pharmaceuticals Inc is listed in 1 LCA filings in FY2023 and 5 in FY2026. The average listed offered wage increased from $185,000 to $185,920. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 21 LCAs (Δ 0 heavier vs Janssen pharmaceuticals Inc); CERT-LOCK · WAGE-ELITE vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 21 LCAs (Δ 0 heavier vs Janssen pharmaceuticals Inc); CERT-LOCK · WAGE-PAR vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 21 LCAs (Δ 0 heavier vs Janssen pharmaceuticals Inc); CERT-SOFT · WAGE-BELOW vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
ABS(total_petitions) peer at 21 LCAs (Δ 0 heavier vs Janssen pharmaceuticals Inc); CERT-LOCK · WAGE-PAR vs this page's MICRO-BOOK · CERT-LOCK · WAGE-ELITE.
NJ pole at 39,678 LCAs stamps MEGA-BOOK · CERT-CLEAN, farthest ABS(total_petitions) contrast from Janssen pharmaceuticals Inc's MICRO-BOOK.
Open the NJ state board after the ABS peers. Janssen pharmaceuticals Inc stamps MICRO-BOOK · CERT-LOCK inside that worksite mix.
Janssen pharmaceuticals Inc's WAGE-ELITE offered-wage posture needs occupation/state context, not a shared guide card.
What to do with this profile
Use the DOL LCA record for Janssen pharmaceuticals Inc to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.